Marja-Liisa Sumelahti

13PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyAutoimmunityRegenerative medicine (incl. stem cells)Ngā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 01, 2026
Cancer risk and mortality in patients with multiple sclerosis in Finland: a retrospective population-based cohort study.

|Jan 28, 2026
Clinical and genetic characterization of non-optimal triptan response among migraine patients.

Ettore Brenna, Matteo Ferro, Marja-Liisa Sumelahti

|Dec 10, 2025
Immunometabolic profiling in menopausal women with multiple sclerosis: the role of adipokines and hormone therapy.

Laura Juutinen, Katja Ahinko, Sanna Hagman

|Nov 05, 2025
Guiding Multiple Sclerosis Care: An Update to the 2013 Consensus Statement from the MS in the 21st Century Steering Group.

Raed Alroughani, Elisabeth G Celius, Helen Gray

|Oct 01, 2025
Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study.

Messoud Ashina, Dimos D Mitsikostas, Faisal Mohammad Amin

|Mar 18, 2025
Incidence and prevalence of multiple sclerosis during eras of evolving diagnostic criteria-a nationwide population-based registry study over five decades.

Anna Maunula, Sini M Laakso, Matias Viitala

Pageof 3

Frequent Collaborators

2 joint publications

Christoph J Schankin

2 joint publications

Patricia Pozo-Rosich

2 joint publications

Isabel Pavão Martins

2 joint publications

Cristina Tassorelli